Cinven To Pay HgCapital £465 Million For Drugmaker Mercury
Private equity firm Cinven will pay fellow British investment house HgCapital £465 million (US$730 million) for Mercury Pharma Group Ltd., giving the buyer a niche drugmaker it hopes to use as...To view the full article, register now.
Already a subscriber? Click here to view full article